OnCo

No description yet: the sentence for this tag has not been written. 4 records carry it: 4 people.

4 records
Andrea Necchi
Head of Genitourinary Medical Oncology, IRCCS San Raffaele Hospital; Professor, Vita-Salute San Raffaele University · IRCCS Ospedale San Raffaele
Led PURE-01, the first neoadjuvant pembrolizumab trial in bladder cancer, and now leads bladder-preserving immunotherapy studies.
Domenica Lorusso
Director of Gynaecological Oncology, Humanitas San Pio X and Humanitas University, Milan · IRCCS Humanitas Research Hospital
Led KEYNOTE-A18, which showed adding pembrolizumab to chemoradiotherapy improves survival in locally advanced cervical cancer.
Paolo A. Ascierto
Director, Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples · Istituto Nazionale Tumori IRCCS Fondazione G. Pascale
Italian melanoma oncologist who co-led CheckMate 238, CheckMate 067 and the COLUMBUS BRAF/MEK trial.
Silvia Stacchiotti
Medical Oncologist, Adult Mesenchymal Tumour and Rare Cancer Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan · Fondazione IRCCS Istituto Nazionale dei Tumori
Italian oncologist who leads histology-specific trials in ultra-rare sarcomas and the Connective Tissue Oncology Society.

This tag as JSON · API